• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - COSTA RICA (COYOL) JAGWIRE¿; ENDOSCOPIC GUIDEWIRE, GASTROENTEROLOGY-UROLOGY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - COSTA RICA (COYOL) JAGWIRE¿; ENDOSCOPIC GUIDEWIRE, GASTROENTEROLOGY-UROLOGY Back to Search Results
Model Number M00556581
Device Problems Detachment Of Device Component (1104); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  Injury  
Manufacturer Narrative
(b)(6).The complainant indicated that the device will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that a jagwire was used during a lower limb angioplasty procedure.According to the complainant, during procedure, the physician observed that the floppy tip of the guidewire was peeling and offering risk of embolization of intravascular foreign body.Additionally, the directions for use indicate "the jagwire high performance guidewire is indicated for use in selective cannulation of the biliary ducts including, but not limited to the common bile, cystic, right and left hepatic ducts.The jagwire high performance guidewire is designed to be used during endoscopic biliary procedures for catheter introduction and exchanges.Attempts to obtain additional information regarding the circumstances surrounding this event have been unsuccessful to date.Should additional relevant details become available, a supplemental report will be submitted.
 
Event Description
It was reported to boston scientific corporation that a jagwire was used during a lower limb angioplasty procedure.According to the complainant, during procedure, the physician observed that the floppy tip of the guidewire was peeling and offering risk of embolization of intravascular foreign body.Additionally, the directions for use indicate "the jagwire high performance guidewire is indicated for use in selective cannulation of the biliary ducts including, but not limited to the common bile, cystic, right and left hepatic ducts.The jagwire high performance guidewire is designed to be used during endoscopic biliary procedures for catheter introduction and exchanges.Attempts to obtain additional information regarding the circumstances surrounding this event have been unsuccessful to date.Should additional relevant details become available, a supplemental report will be submitted.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported to boston scientific corporation that a jagwire was used during a lower limb angioplasty procedure.According to the complainant, during procedure, the physician observed that the floppy tip of the guidewire was peeling and offering risk of embolization of intravascular foreign body.Additionally, the directions for use indicate "the jagwire high performance guidewire is indicated for use in selective cannulation of the biliary ducts including, but not limited to the common bile, cystic, right and left hepatic ducts.The jagwire high performance guidewire is designed to be used during endoscopic biliary procedures for catheter introduction and exchanges.Attempts to obtain additional information regarding the circumstances surrounding this event have been unsuccessful to date.Should additional relevant details become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Correction: adverse event or product problem, (outcomes attributed to adverse event).
 
Event Description
It was reported to boston scientific corporation that a jagwire was used during a lower limb angioplasty procedure.According to the complainant, during procedure, the physician observed that the floppy tip of the guidewire was peeling and offering risk of embolization of intravascular foreign body.Additionally, the directions for use indicate "the jagwire high performance guidewire is indicated for use in selective cannulation of the biliary ducts including, but not limited to the common bile, cystic, right and left hepatic ducts.The jagwire high performance guidewire is designed to be used during endoscopic biliary procedures for catheter introduction and exchanges.Attempts to obtain additional information regarding the circumstances surrounding this event have been unsuccessful to date.Should additional relevant details become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JAGWIRE¿
Type of Device
ENDOSCOPIC GUIDEWIRE, GASTROENTEROLOGY-UROLOGY
Manufacturer (Section D)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS 
Manufacturer (Section G)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS  
Manufacturer Contact
nancy cutino
100 boston scientific way
marlborough, MA 01752
5086834000
MDR Report Key6747566
MDR Text Key81183984
Report Number3005099803-2017-02238
Device Sequence Number1
Product Code OCY
UDI-Device Identifier08714729339151
UDI-Public(01)08714729339151(17)20180901(10)18363526
Combination Product (y/n)N
PMA/PMN Number
K141820
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup,Followup
Report Date 07/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/01/2018
Device Model NumberM00556581
Device Catalogue Number5658
Device Lot Number18363526
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/04/2017
Initial Date FDA Received07/27/2017
Supplement Dates Manufacturer Received09/01/2017
09/11/2017
09/13/2017
Supplement Dates FDA Received09/01/2017
09/12/2017
09/14/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/03/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-